Recombinant human FIZZ3/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice

Endocrinology

Volumn 146, Issue 5, 2005, Pages 2200-2209

  Ort, Tatiana ^a   Arjona, Anibal A ^a   MacDougall, John R ^a   Nelson, Pam J ^a   Rothenberg, Mark E ^a   Wu, Frank ^a   Eisen, Andrew ^a   Halvorsen, Yuan Di C ^a  

^a CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; PROTEIN KINASE B; RECOMBINANT HORMONE; RESISTIN; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; ENERGY EXPENDITURE; ESTERIFICATION; FATTY ACID TRANSPORT; GLUCOSE TRANSPORT; GLYCEROL BLOOD LEVEL; HUMAN; HUMAN CELL; LIPOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; ESTERIFICATION; FATTY ACIDS; GLUCOSE; GLYCEROL; HORMONES, ECTOPIC; HUMANS; INSULIN; LIPOLYSIS; MICE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; RESISTIN; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 17744377650     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1421     Document Type: Article

References (39)

1. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale Jr FV, Shelton DL, Hebert CC 2000 FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046-4055
2. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409:307-312
3. Kim KH, Lee K, Moon YS, Sul HS 2001 A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252-11256
4. Pravenec M, Kazdova L, Landa V, Zidek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW 2003 Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 278:45209-45215
5. Rajala MW, Obici S, Scherer PE, Rossetti L 2003 Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 111:225-230
6. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, Wang J, Rajala MW, Pocai A, Scherer PE, Steppan CM, Ahima RS, Obici S, Rossetti L, Lazar MA 2004 Regulation of fasted blood glucose by resistin. Science 303:1195-1198
7. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE, Rossetti L 2004 Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 114:232-239
8. Kim KH, Zhao L, Moon Y, Kang C, Sul HS 2004 Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA 101:6780-6785
9. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM 2004 Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114:224-231
10. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S 2002 Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47
11. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu Q, Considine RV 2003 Serum resista (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88:5452-5455
12. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T 2003 Correlation between serum resista level and adiposity in obese individuals. Obes Res 11:997-1001
13. Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C, Mantzoros CS 2003 Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88:4848-4856
14. Nagaev I, Smith U 2001 Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564
15. McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, Clark PM, Smith SA, Barnett AH, Kumar S 2003 Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 88:6098-6106
16. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA 2003 Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem Biophys Res Commun 300:472-476
17. Fain JN, Cheema PS, Bahouth SW, Lloyd Hiler M 2003 Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300:674-678
18. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S 2001 Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50:2199-2202
19. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
20. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808
21. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR 2003 Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309:286-290
22. Yan H, Aziz E, Shillabeer G, Wong A, Shanghavi D, Kermouni A, Abdel-Hafez M, Lau DC 2002 Nitric oxide promotes differentiation of rat white preadipocytes in culture. J Lipid Res 43:2123-2129
23. Shillabeer G, Li ZH, Hatch G, Kumar V, Lau DC 1996 A novel method for studying preadipocyte differentiation in vitro. Int J Obes Relat Metab Disord 20(Suppl 3):S77-S83
24. Rocchi S, Picard F, Vamecq J, Gelman L, Potier N, Zeyer D, Dubuquoy L, Bac P, Champy MF, Plunket KD, Leesnitzer LM, Blanchard SG, Desreumaux P, Moras D, Renaud JP, Auwerx J 2001 A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell 8:737-747
25. Gocze PM, Freeman DA 1994 Factors underlying the variability of lipid droplet fluorescence in MA-10 Leydig tumor cells. Cytometry 17:151-158
26. Decherchi P, Cochard P, Gauthier P 1997 Dual staining assessment of Schwann cell viability within whole peripheral nerves using calcein-AM and ethidium homodimer. J Neurosci Methods 71:205-213
27. Nohira T, Nagao K, Kameyama K, Nakai H, Fukumine N, Okabe K, Kitano S, Hisatomi H 2004 Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue. Eur J Endocrinol 151:151-154
28. Calabio P, Samudio I, Willerson JT, Yeh ET 2004 Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 110:3335-3340
29. Fletcher DS, Candelore MR, Grujic D, Lowell BB, Luell S, Susulic VS, Macintyre DE 1998 β-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the β-3 adrenergic receptor. J Pharmacol Exp Ther 287:720-724
30. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS 2002 Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51:2929-2935
31. Greenberg AS, Shen WJ, Muliro K, Patel S, Souza SC, Roth RA, Kraemer FB 2001 Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J Biol Chem 276:45456-64541
32. Tordjman J, Chauvet G, Quette J, Beale EG, Forest C, Antoine B 2003 Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 278:18785-18790
33. Reidy SP, Weber JM 2002 Accelerated substrate cycling: a new energy-wasting role for leptin in vivo. Am J Physiol 282:E312-E317
34. Wolfe RR, Klein S, Carraro F, Weber JM 1990 Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 258:E382-E329
35. Blagoev B, Kratchmarova I, Nielsen MM, Fernandez MM, Voldby J, Andersen JS, Kristiansen K, Pandey A, Mann M 2002 Inhibition of adipocyte differentiation by resistin-like molecule α. Biochemical characterization of its oligomeric nature. J Biol Chem 277:42011-42016
36. Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS 2003 Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88:1730-1736
37. Stejskal D, Proskova J, Adamovska S, Jurakova R, Bartek J 2002 Preliminary experience with resistin assessment in common population. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 146:47-49
38. Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L 2004 Disulfide-dependent multimeric assembly of resistin family hormones. Science 304:1154-1158
39. Aruna B, Ghosh S, Singh AK, Mande SC, Srinivas V, Chauhan R, Ehtesham NZ 2003 Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages. Biochemistry 42:10554-10559